### **Overview** Emami Limited, founded in 1974 and headquartered in Kolkata, West Bengal, is a leading Indian FMCG and healthcare company with a strong heritage in **Ayurveda**, **personal care**, and **lifestyle wellness**. With a diversified portfolio of over **550 products** and presence in **over 70 countries**, Emami has evolved from a domestic rural-focused brand developer into a modern, global, tech-enabled enterprise. The company combines traditional Ayurvedic wisdom with cutting-edge science, digital innovation, and strategic acquisitions to drive sustainable, profitable growth across multiple high-potential categories. --- ### **Core Business Segments & Key Brands** Emami operates across three major platforms: 1. **Personal Care & Grooming** – BoroPlus, Navratna, Smart and Handsome, The Man Company, Kesh King, 7 Oils in One 2. **Healthcare & Ayurveda** – Zandu, Zanducare, Chyawanprash, Pancharishta, Pure Honey 3. **International & Global Brands** – Creme21, Dermicool, Brillare **Flagship Brands**: - **Navratna** (herbal cool oil, market leader with 66.4% share) - **BoroPlus** (ayurvedic skincare, 60%+ market share in antiseptic cream) - **Zandu** (pain management, household penetration of 20.3%) - **Kesh King** (medicinal hair oil, “India’s No. 1 Hairfall Expert”) - **Smart and Handsome** (rebranded from Fair and Handsome; holistic male grooming) - **Dermicool** (prickly heat and cool talc; #1 player post-acquisition) - **The Man Company & Brillare** (premium D2C male grooming & salon-grade skincare) --- ### **Strategic Focus & Growth Engines** #### **1. Digital Transformation & D2C Leadership** - **Zanducare**, Emami’s **D2C e-commerce platform**, launched over **100 digital-first products**, contributing to 45% of total revenue via high-growth engines. - Zanducare grew **59% YoY** in FY25, with **over 80% of its sales from digital-first items**; products launched in the last two years contribute ~50% of its revenue. - The platform offers **personalized recommendations**, **free doctor consultations**, **telemedicine**, and enhanced **UI/UX**, with the app redesigned for faster checkout and loyalty rewards. - Zanducare contributes **10%+ to healthcare product sales**, up from 8% in FY23, with **11.5 million unique visitors in FY24**. #### **2. Inorganic Growth & Startup Investments** - Emami follows a **strategic inorganic growth model** by investing early in high-potential **new-age D2C startups** in emerging categories: - **The Man Company** (premium male grooming) – fully acquired, now EBITDA-positive - **Brillare** (salon skincare) – growing fast, present in 3,000+ outlets - **Furball Story** (pet care) - **Trunativ** (protein nutrition) - **AloFrut** (aloe vera + fruit juices) – invested ₹129 crore in FY23 - These subsidiaries now **collectively contribute over 5% of total revenue** and are part of a ₹200+ crore investment pipeline. - The strategy enables **agile innovation**, **brand diversification**, and **category expansion** while leveraging Emami’s scale, distribution, and R&D infrastructure. #### **3. Distribution & Channel Optimization** - **Shift from scale to profitability**: Emami is refocusing from broad distribution to **high-throughput, high-margin retail outlets**. - **Project Emami One Field Services (EOFS)** standardizes in-store branding and enhances shopper engagement in top retail chains. - **5,600 General Trade (GT) Marts** established as strategic hubs, driving **45% YoY growth** in this channel. - Organized channel contribution increased from **12% in FY20 to ~28% in FY25**, with **nearly 45% of total revenue now from high-growth channels**: - E-commerce - Modern trade - Institutional channels - Subsidiaries (The Man Company, Brillare) - International business #### **4. Brand Repositioning & Innovation** - **Rebranded “Fair & Handsome” to “Smart and Handsome”** in 2025, shifting from fairness to **holistic male grooming** across face, body, and hair. - Expanded total addressable market from ₹759 crore to **₹6,700 crore** - Rebranded line now accounts for 7% YoY growth in Q4 FY25 - New brand ambassador: **Kartik Aaryan**, targeting younger consumers - **Dermicool** expanded from seasonal talc to a **multi-product franchise**: - Launched **Dermicool Her**, **Super Active Talc**, **Shower Gels**, and **Prickly Heat Spray** - Achieved **8.7% household penetration** and **43.4% volume market share** - Continuous innovation in **non-seasonal formats** (e.g., Kesh King anti-dandruff shampoo, BoroPlus Aloe Vera Gel) reduces reliance on seasonal demand. --- ### **International Business** - **17% of consolidated revenue** comes from international operations (up from 15% in FY20), growing at **11% CAGR over five years**. - Operates in **70+ countries** across **Middle East, Africa, SEA, SAARC, and Russia-CIS**. - **85% of international workforce** is locally hired, ensuring **cultural alignment** and **operational agility**. - **80% of international production and sourcing** is localized (Germany, Bangladesh, UAE, Sri Lanka, Thailand). - Key international brands: - **7 Oils in One** – ₹100+ crore in international sales; strong in Bangladesh - **Creme21** – German skincare brand thriving in GCC and SAARC - **BoroPlus**, **Navratna**, **Zandu**, **Smart and Handsome** – category leaders in multiple markets - Focus on **top 15 countries** accounting for **~80% of overseas revenues**. --- ### **R&D & Innovation Capability** - Emami operates **state-of-the-art R&D centers in Kolkata (30,000 sq. ft.) and Mumbai**, DSIR and NABL certified. - R&D team includes **100+ scientists**, including PhDs, Ayurvedacharyas, and specialists in **phytochemistry, dermatology, pharmacology, and biotechnology**. - Key capabilities: - **Tech Intel Playbook**: AI-driven predictive analytics for product development - **Design-to-Value (DTV)**: Optimizes formulations for affordability without compromising quality - **Ready-to-Deploy toolboxes** for rapid D2C innovation - **Clinical validation** via partnerships with **AIIMS, NIMHANS, and Ayurvedic universities** - Phase I trials completed for a **phytopharmaceutical pre-diabetes drug** - Cultivates **medicinal plants** (Brahmi, Tulsi, Kaunch) through **organic farming and hydroponics**. --- ### **Manufacturing & Supply Chain** - **6 manufacturing units**: 5 in India (Vapi, Masat, Pantnagar, Pacharia, Amingaon), 1 in **Bangladesh**. - Supported by **35+ third-party partners** in Germany, UAE, Sri Lanka, Russia, and Thailand. - **WHO GMP, ISO, and cGMP certified** facilities. - **Digitized supply chain** with **mSFA, RFID, geo-tagging**, and **beat optimization tools** for rural and urban execution. - **Project Khoj** expanded rural reach to **over 50,000 towns**, supported by geo-mapping and digital sales tools. --- ### **Financial & Strategic Highlights (FY25)** - **Core Domestic Business**: Grew **8% (value)** and **5% (volume)** despite macro headwinds. - **Key brand growth**: - Navratna & Dermicool: **+18%** - BoroPlus: **+14%** - Zandu Healthcare: **+12%** - **E-commerce & Modern Trade**: - E-commerce now **~12% of sales**, with **82% YoY growth** in prior years - Modern trade grew **37%**, enabled by **Project Midas** and **joint business planning** - **International Sales**: +11% CAGR, **5% growth in constant currency** in FY25 - **Cash-rich, zero-debt balance sheet** – supports **acquisition flexibility and R&D investment** - **8 brands now generate >₹100 crore annually**, including Zandu (₹800Cr+), Navratna (₹600Cr+), BoroPlus (₹500Cr+)